Concepts (90)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Colon | 9 | 2024 | 119 | 1.460 |
Why?
|
| Irritable Bowel Syndrome | 6 | 2024 | 32 | 1.300 |
Why?
|
| Urinary Bladder | 6 | 2021 | 118 | 1.200 |
Why?
|
| Rats, Sprague-Dawley | 10 | 2024 | 542 | 0.960 |
Why?
|
| Gastrointestinal Transit | 2 | 2018 | 8 | 0.680 |
Why?
|
| Peptides | 2 | 2018 | 279 | 0.650 |
Why?
|
| Cystitis, Interstitial | 4 | 2021 | 17 | 0.650 |
Why?
|
| Ghrelin | 1 | 2018 | 7 | 0.650 |
Why?
|
| Visceral Pain | 4 | 2024 | 20 | 0.640 |
Why?
|
| Biomimetic Materials | 1 | 2018 | 20 | 0.630 |
Why?
|
| Guanylate Cyclase | 1 | 2018 | 14 | 0.620 |
Why?
|
| Rats | 12 | 2024 | 1539 | 0.620 |
Why?
|
| Piperidines | 1 | 2018 | 42 | 0.620 |
Why?
|
| Disease Models, Animal | 5 | 2024 | 1391 | 0.520 |
Why?
|
| Colitis | 1 | 2024 | 52 | 0.470 |
Why?
|
| Stress, Psychological | 4 | 2024 | 207 | 0.350 |
Why?
|
| Animals | 14 | 2024 | 9927 | 0.340 |
Why?
|
| Proto-Oncogene Proteins c-ret | 2 | 2018 | 16 | 0.320 |
Why?
|
| Gastrointestinal Motility | 2 | 2018 | 30 | 0.320 |
Why?
|
| Permeability | 5 | 2021 | 58 | 0.320 |
Why?
|
| Receptors, Glucocorticoid | 2 | 2023 | 18 | 0.250 |
Why?
|
| Corticotropin-Releasing Hormone | 2 | 2023 | 28 | 0.250 |
Why?
|
| Spinal Cord | 2 | 2024 | 202 | 0.240 |
Why?
|
| Epigenesis, Genetic | 2 | 2023 | 144 | 0.220 |
Why?
|
| Magnetic Resonance Imaging | 3 | 2021 | 798 | 0.190 |
Why?
|
| Central Amygdaloid Nucleus | 1 | 2021 | 6 | 0.190 |
Why?
|
| Calcitonin Gene-Related Peptide | 1 | 2021 | 27 | 0.190 |
Why?
|
| Environment | 1 | 2021 | 60 | 0.190 |
Why?
|
| Biopolymers | 1 | 2021 | 14 | 0.190 |
Why?
|
| Claudin-2 | 1 | 2020 | 4 | 0.180 |
Why?
|
| Administration, Oral | 2 | 2018 | 166 | 0.180 |
Why?
|
| Molecular Probes | 1 | 2020 | 13 | 0.180 |
Why?
|
| Glycosaminoglycans | 1 | 2021 | 54 | 0.180 |
Why?
|
| Antibodies, Monoclonal | 1 | 2021 | 316 | 0.170 |
Why?
|
| Male | 7 | 2024 | 12826 | 0.170 |
Why?
|
| Cholinergic Neurons | 1 | 2018 | 5 | 0.160 |
Why?
|
| Ion Transport | 1 | 2018 | 11 | 0.160 |
Why?
|
| Administration, Intravenous | 1 | 2018 | 25 | 0.160 |
Why?
|
| Female | 9 | 2023 | 14405 | 0.160 |
Why?
|
| Guanylyl Cyclase C Agonists | 1 | 2018 | 1 | 0.160 |
Why?
|
| Hyperalgesia | 1 | 2018 | 16 | 0.160 |
Why?
|
| Proteoglycans | 1 | 2018 | 37 | 0.150 |
Why?
|
| Enzyme Activation | 1 | 2018 | 262 | 0.150 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2018 | 142 | 0.150 |
Why?
|
| Intestinal Mucosa | 1 | 2018 | 186 | 0.140 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2018 | 587 | 0.140 |
Why?
|
| Rats, Long-Evans | 3 | 2021 | 34 | 0.130 |
Why?
|
| Signal Transduction | 2 | 2018 | 1335 | 0.120 |
Why?
|
| Trinitrobenzenesulfonic Acid | 1 | 2024 | 14 | 0.120 |
Why?
|
| Ganglia, Spinal | 1 | 2024 | 25 | 0.120 |
Why?
|
| Receptors, Serotonin, 5-HT3 | 1 | 2014 | 1 | 0.120 |
Why?
|
| Serotonin 5-HT3 Receptor Antagonists | 1 | 2014 | 1 | 0.120 |
Why?
|
| Receptors, Neurokinin-1 | 1 | 2014 | 2 | 0.120 |
Why?
|
| Extracellular Signal-Regulated MAP Kinases | 1 | 2024 | 44 | 0.120 |
Why?
|
| Quinuclidines | 1 | 2014 | 10 | 0.120 |
Why?
|
| Isoquinolines | 1 | 2014 | 14 | 0.120 |
Why?
|
| Analgesics | 1 | 2024 | 34 | 0.120 |
Why?
|
| Nociceptive Pain | 1 | 2014 | 11 | 0.120 |
Why?
|
| Plant Extracts | 1 | 2024 | 62 | 0.120 |
Why?
|
| Pyridines | 1 | 2014 | 99 | 0.110 |
Why?
|
| Phosphorylation | 1 | 2024 | 558 | 0.110 |
Why?
|
| Rats, Inbred F344 | 2 | 2021 | 167 | 0.100 |
Why?
|
| Abdominal Pain | 2 | 2023 | 34 | 0.090 |
Why?
|
| Mice, Transgenic | 2 | 2021 | 487 | 0.080 |
Why?
|
| Pregnancy | 2 | 2021 | 1126 | 0.070 |
Why?
|
| Histones | 1 | 2023 | 90 | 0.050 |
Why?
|
| Protamines | 1 | 2021 | 11 | 0.050 |
Why?
|
| Gadolinium DTPA | 1 | 2020 | 14 | 0.050 |
Why?
|
| Ovariectomy | 1 | 2021 | 53 | 0.050 |
Why?
|
| Serum Albumin | 1 | 2020 | 35 | 0.050 |
Why?
|
| Mice | 2 | 2020 | 4393 | 0.040 |
Why?
|
| Antibodies | 1 | 2020 | 124 | 0.040 |
Why?
|
| Lipopolysaccharides | 1 | 2020 | 151 | 0.040 |
Why?
|
| Immunohistochemistry | 1 | 2020 | 453 | 0.040 |
Why?
|
| A549 Cells | 1 | 2018 | 16 | 0.040 |
Why?
|
| Cholinergic Agonists | 1 | 2018 | 6 | 0.040 |
Why?
|
| Defecation | 1 | 2018 | 11 | 0.040 |
Why?
|
| Choline O-Acetyltransferase | 1 | 2018 | 8 | 0.040 |
Why?
|
| Enteric Nervous System | 1 | 2018 | 10 | 0.040 |
Why?
|
| Administration, Intravesical | 1 | 2018 | 16 | 0.040 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2018 | 56 | 0.040 |
Why?
|
| Animals, Newborn | 1 | 2018 | 163 | 0.040 |
Why?
|
| Recombinant Proteins | 1 | 2018 | 407 | 0.030 |
Why?
|
| Neurokinin-1 Receptor Antagonists | 1 | 2014 | 2 | 0.030 |
Why?
|
| Cell Line, Tumor | 1 | 2018 | 1256 | 0.030 |
Why?
|
| Posterior Horn Cells | 1 | 2014 | 10 | 0.030 |
Why?
|
| Drug Combinations | 1 | 2014 | 50 | 0.030 |
Why?
|
| Drug Synergism | 1 | 2014 | 100 | 0.030 |
Why?
|
| Humans | 3 | 2021 | 26749 | 0.030 |
Why?
|
| Action Potentials | 1 | 2014 | 193 | 0.030 |
Why?
|